股东减持

Search documents
拱东医疗控股股东等拟合计减持不超3%股份
Zhi Tong Cai Jing· 2025-09-04 10:37
Core Viewpoint - Gongdong Medical (605369.SH) announced that its controlling shareholder and actual controller, Shi Huiyong, plans to reduce holdings through block trading, with a maximum of 4.4099 million shares, not exceeding 2% of the total share capital within three months after the announcement [1] Summary by Category - **Shareholder Reduction Plans** - Shi Huiyong intends to reduce holdings by up to 4.4099 million shares through block trading, within three months after the announcement [1] - Jincheng Investment plans to reduce holdings by up to 2.2049 million shares through centralized bidding, not exceeding 1% of the total share capital [1]
同为股份:公司会在收到公司股东减持计划实施情况相关告知函后及时履行信息披露义务
Zheng Quan Ri Bao Wang· 2025-09-04 09:40
Group 1 - The company, Tongwei Co., Ltd. (002835), announced on September 4 that it will fulfill its information disclosure obligations promptly after receiving the notice regarding the implementation of the shareholder reduction plan [1] - Investors are advised to pay attention to the company's subsequent announcements related to this matter [1]
路维光电股东国投创业基金减持 187 万股,套现 5841 万元
Xin Lang Cai Jing· 2025-09-04 09:06
深圳市路维光电股份有限公司发布股东减持股份结果公告。减持计划实施前,股东国投创业基金持有公 司 11,217,912 股,占总股本 5.80%。5 月 13 日,该股东计划减持不超 1,933,338 股,即不超总股本 1.00%。截至 9 月 4 日,国投创业基金已通过集中竞价、大宗交易累计减持 1,872,205 股,占总股本 0.97%,减持价格 29.50 - 44.02 元/股,减持总金额 58,411,838 元,未完成减持 61,133 股,当前持股比例 降至 4.83%。本次减持符合计划,未提前终止。 ...
隆达股份:国联产投减持0.9997%完成
Xin Lang Cai Jing· 2025-09-04 08:47
Summary of Key Points Core Viewpoint - Wuxi Guolian Industrial Upgrade Investment Center (Limited Partnership), a shareholder holding more than 5% of Longda Co., Ltd., has completed its share reduction plan, selling 2,467,700 shares, which accounts for 0.9997% of the company's total share capital, at a transaction price ranging from 17.3 to 22.82 yuan per share [1] Group 1 - The share reduction period was from June 5, 2025, to September 4, 2025 [1] - Prior to the reduction, Wuxi Guolian held 21,556,300 shares, representing 8.73% of the total shares [1] - After the reduction, Wuxi Guolian now holds 19,088,600 shares, which is 7.73% of the total shares, consistent with the original plan to reduce no more than 2,468,571 shares, or no more than 1% [1]
聚合顺实控人方拟减持2年前套现8372万 A股募10.98亿
Zhong Guo Jing Ji Wang· 2025-09-04 06:56
Core Viewpoint - Hainan Yongchang New Materials Co., Ltd., a major shareholder of Juhe Shun (605166.SH), announced a plan to reduce its shareholding due to its own funding needs, intending to sell up to 9,441,700 shares, which represents a maximum of 3% of the company's total share capital [1][2]. Shareholding Structure - As of the announcement date, Hainan Yongchang holds 34,868,538 shares, accounting for 11.08% of the total share capital of 314,729,307 shares [2]. - The combined shareholding of Fu Changbao, Hainan Yongchang, and Wenzhou Yongchang Holdings Co., Ltd. amounts to 110,084,588 shares, representing 34.98% of the total shares [2]. Reduction Plan Details - The reduction plan includes selling up to 3,147,200 shares through centralized bidding and up to 6,294,500 shares through block trading, with the reduction period set from September 25, 2025, to December 24, 2025 [1]. - Previous reductions by Hainan Yongchang from August 28, 2023, to September 24, 2023, involved selling 9,432,300 shares, which accounted for 2.989% of the total shares, generating a total amount of 83,720,473 yuan [3][4]. Fundraising Activities - Juhe Shun raised a total of 1.098 billion yuan through three fundraising activities, including an IPO and two rounds of convertible bond issuances [8]. - The funds raised are allocated for various projects, including the production of polyamide 6 chips and the establishment of a research and development center [5][7].
天融信大股东减持套现9900万元 上半年亏损6469万元
Zhong Guo Jing Ji Wang· 2025-09-04 06:01
天融信表示,郑钟南的本次变动涉及的股份减持行为,均为履行已披露的2次股份减持计划。公司于2021年5月25日披露了《关于持股5%以上股东减 持股份预披露公告》(公告编号:2021-048);公司于2025年8月12日披露了《关于持股5%以上股东减持股份预披露公告》(公告编号:2025-039)。 截至公告披露日,本次减持与此前已披露的2次减持计划和相关承诺一致,减持数量在已披露的减持计划范围内。 本次变动后,郑钟南于2025年8月12日披露的股份减持计划尚未实施完毕,后续其将严格按照相关法律法规及规范性文件的要求及时披露减持进展 公告。 天融信2024年年报显示,郑钟南为公司第一大股东。公司于2020年10月26日召开2020年第四次临时股东大会和第六届董事会第一次会议,选举产生 了公司第六届董事会成员并聘任了公司高级管理人员。会议召开后,公司根据《公司法》《上市公司收购管理办法》以及《深圳证券交易所股票上市规 则》等法律法规的相关规定,结合公司股权结构和董事会成员提名情况,公司股东大会、董事会的表决机制和程序设定,以及是否存在管理层控制、多 个股东共同控制或管理层与股东共同控制情况,对公司控制权情况进行了谨 ...
破发连亏股宝兰德股东拟减持 IPO募7.9亿东兴证券保荐
Zhong Guo Jing Ji Wang· 2025-09-04 06:01
中国经济网北京9月4日讯 今日,宝兰德(688058.SH)昨日晚间披露持股5%以上股东减持股份计划公告。 因自身资金安排,公司持股5%以上股东北京易东兴股权投资中心(有限合伙)(以下简称"易东兴")计划以集中竞价、大宗交易的方 式减持其所持有的公司股份合计减持不超过1,165,000股,即不超过公司总股本的1.50%。 因个人资金需求,公司股东赵艳兴计划以集中竞价、大宗交易的方式减持其所持有的公司股份合计减持不超过1,165,000股,即不超过 公司总股本的1.50%。 减持期间为自公告披露之日起15个交易日后的3个月内。减持价格将按照减持实施时的市场价格确定。若减持期间公司发生派息、送 股、资本公积金转增股本、配股等除权除息事项,减持股份数量、减持价格将进行相应调整。 截至公告披露日,易东兴持有公司股份5,522,738股,占公司总股本的比例为7.10%;赵艳兴直接持有公司股份3,468,312股,占公司总股 本的比例为4.46%。上述股份均为无限售流通股且来源于公司首次公开发行前及资本公积转增股本取得的股份。 公告显示,赵艳兴对易东兴日常经营管理及决策具有重大影响,赵艳兴可控制易东兴,并与易东兴保持一致 ...
浙江莎普爱思药业股份有限公司 关于全资子公司获得盐酸毛果芸香碱滴眼液临床试验批准通知书的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-09-03 23:06
Group 1 - The core point of the announcement is that Zhejiang Shapuaisi Pharmaceutical Co., Ltd.'s wholly-owned subsidiary has received approval for clinical trials of a new eye drop medication, which is intended for the treatment of presbyopia in adults [1][2]. - The drug, named Pilocarpine Hydrochloride Eye Drops, is classified as a Class 3 chemical drug and is currently in the clinical trial phase [1][3]. - The total research and development investment for the Pilocarpine Hydrochloride Eye Drops project has reached approximately 6.4457 million RMB [3]. Group 2 - The major shareholder, Mr. Chen Dekang, holds 43,871,004 shares, accounting for 11.67% of the total share capital of the company [7]. - Mr. Chen plans to reduce his holdings by up to 3,759,250 shares through centralized bidding and another 3,759,250 shares through block trading, totaling a maximum of 7,518,500 shares, which is 2.00% of the total share capital [7][8]. - The reduction plan is due to personal financial needs and will take place from September 25, 2025, to December 24, 2025 [7].
彤程新材: 彤程新材料集团股份有限公司股东减持股份计划公告
Zheng Quan Zhi Xing· 2025-09-03 16:29
证券代码:603650 证券简称:彤程新材 公告编号:2025-066 债券代码:113621 债券简称:彤程转债 彤程新材料集团股份有限公司 股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: | 股东名称 | 舟山市宇彤创业投资合伙企业(有限合伙) | | | | | --- | --- | --- | --- | --- | | 股东身份 | 控股股东、实控人及一致行动人 | | □是 | √否 | | | 直接持股 5%以上股东 □是 | √否 | | | | | 董事、监事和高级管理人员 | □是 | √否 | | | | 其他:5%以下股东 | | | | | 持股数量 | 23,894,623股 | | | | | 持股比例 | 3.99% | | | | IPO 前取得:22,706,723股 当前持股股份来源 集中竞价交易取得:1,187,900股 二、减持计划的主要内容 股东名称 舟山市宇彤创业投资合伙企业(有限合伙) 计划减持数量 不超过:13,000,000 ...
信科移动: 持股5%以上股东及其一致行动人集中竞价减持股份计划公告
Zheng Quan Zhi Xing· 2025-09-03 16:29
Core Viewpoint - The announcement details a share reduction plan by major shareholders of Zhongxin Ke Mobile Communication Technology Co., Ltd. due to their funding needs, involving a maximum reduction of 34,187,500 shares, which is up to 1% of the company's total share capital [1][2][3]. Group 1: Shareholder Information - As of the announcement date, the National Development Manufacturing Transformation and Upgrade Fund (National Development Fund) holds 280,000,000 shares, accounting for 8.19% of the total shares, while National Development Science and Technology Venture Capital Co., Ltd. holds 10,000,000 shares, accounting for 0.29% [1]. - The combined holdings of the National Development Fund and National Development Science and Technology Venture Capital amount to 290,000,000 shares, representing 8.48% of the total shares, and they are considered acting in concert [2][3]. Group 2: Reduction Plan Details - The reduction plan allows for a maximum of 34,187,500 shares to be sold through centralized bidding from September 26, 2025, to December 25, 2025, based on market conditions [3][4]. - The selling price will be determined by the market price at the time of the sale, and the number of shares to be reduced will be adjusted in case of any corporate actions like stock dividends or capital increases [2][3]. Group 3: Compliance and Commitments - The shareholders have committed to not transferring or entrusting the management of their pre-IPO shares and will adhere to the lock-up period requirements as per relevant regulations [4][5]. - The shareholders have previously made commitments regarding their shareholding intentions and reduction intentions, ensuring compliance with legal and regulatory requirements [5][6].